183 related articles for article (PubMed ID: 33744049)
1. The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
Ortiz JR; Robertson J; Hsu JS; Yu SL; Driscoll AJ; Williams SR; Chen WH; Fitzpatrick MC; Sow S; Biellik RJ; Neuzil KM
Vaccine; 2021 Apr; 39(15):2165-2176. PubMed ID: 33744049
[TBL] [Abstract][Full Text] [Related]
2. The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region.
Ortiz JR; Robertson J; Hsu JS; Yu SL; Driscoll AJ; Williams SR; Chen WH; Fitzpatrick MC; Sow S; Biellik RJ; Okwo-Bele JM; Neuzil KM
medRxiv; 2020 Nov; ():. PubMed ID: 32817984
[TBL] [Abstract][Full Text] [Related]
3. The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions.
Ortiz JR; Yu SL; Driscoll AJ; Williams SR; Robertson J; Hsu JS; Chen WH; Biellik RJ; Sow S; Kochhar S; Neuzil KM
Clin Infect Dis; 2022 Jan; 74(2):227-236. PubMed ID: 33949661
[TBL] [Abstract][Full Text] [Related]
4. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
[TBL] [Abstract][Full Text] [Related]
5. National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines.
Williams SR; Driscoll AJ; LeBuhn HM; Chen WH; Neuzil KM; Ortiz JR
Euro Surveill; 2021 Apr; 26(17):. PubMed ID: 33928899
[TBL] [Abstract][Full Text] [Related]
6. Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study.
Leung K; Wu JT; Leung GM
Lancet Public Health; 2021 Sep; 6(9):e674-e682. PubMed ID: 34388389
[TBL] [Abstract][Full Text] [Related]
7. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
8. Latin American forum on immunization services during the COVID-19 pandemic.
Ávila-Agüero ML; Ospina-Henao S; Pirez MC; Gentile Á; Araya S; Brea J; Mendoza L; Falleiros-Arlant LH
Expert Rev Vaccines; 2021 Mar; 20(3):231-234. PubMed ID: 33554682
[No Abstract] [Full Text] [Related]
9. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert.
Temsah MH; Aljamaan F; Alenezi S; Alhasan K; Alrabiaah A; Assiri R; Bassrawi R; Alhaboob A; Alshahrani F; Alarabi M; Alaraj A; Alharbi NS; Halwani R; Jamal A; Al-Eyadhy A; AbdulMajeed N; Alfarra L; Almashdali W; Fayed A; Alzamil F; Barry M; Memish ZA; Al-Tawfiq JA; Alsubaie S
Front Public Health; 2022; 10():878159. PubMed ID: 35400032
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study.
Procter SR; Abbas K; Flasche S; Griffiths U; Hagedorn B; O'Reilly KM; ; Jit M
BMC Med; 2021 Aug; 19(1):198. PubMed ID: 34384441
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine and the cold chain implications for global adoption.
Das MK
Indian J Public Health; 2021; 65(3):307-310. PubMed ID: 34558497
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
14. Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H
BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of SARS-CoV-2 and influenza vaccines in healthcare workers: Results of two vaccination campaigns in a large teaching hospital in Rome.
Pascucci D; Lontano A; Regazzi L; Marziali E; Nurchis MC; Raponi M; Vetrugno G; Moscato U; Cadeddu C; Laurenti P
Hum Vaccin Immunother; 2023 Dec; 19(3):2287282. PubMed ID: 38016914
[TBL] [Abstract][Full Text] [Related]
16. Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.
Mangat HS; Musah A; Luedtke S; Syed AA; Maramattom BV; Maruthanal J; Bosman A; Kostkova P
Front Public Health; 2022; 10():972464. PubMed ID: 36311588
[TBL] [Abstract][Full Text] [Related]
17. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P
Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827
[TBL] [Abstract][Full Text] [Related]
18. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
[TBL] [Abstract][Full Text] [Related]
19. "Implementation of intensified COVID-19 vaccination optimization (ICVOPT) campaigns strategy in complex humanitarian emergency settings and hard-to-reach areas; a case of South Sudan".
Atwongyeire D; Tegegne AA; Ndenzako F; Dineen B; Benjamin AE; Luo B; Melesachew F; George Bachan E; Baguma A
BMC Infect Dis; 2024 May; 24(1):544. PubMed ID: 38816715
[TBL] [Abstract][Full Text] [Related]
20. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
